Hepatitis C - Hepatitis, Viral

Hepatitis, Viral
Management of viral hepatitis C. J Gastroenterol Hepatol. 2002;17 Suppl: S146-S154. Liaw YF, Leung NW, Chang TT, et al. Effects of extended lamivudine

Hepatitis C - Infectious Mononucleosis

Infectious Mononucleosis
Title: Infectious Mononucleosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/14/2005
Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....
Cirrhosis Of The Liver
Title: Cirrhosis Of The Liver
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/1/2005

Hepatitis C - Vaccination Tames Hepatitis A Infection

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A Infection
Category: Health News
Created: 7/13/2005 1:58:00 AM
Last Editorial Review: 7/13/2005 1:58:14 AM
More HCV Treatment News Coverage
The Los Angeles Times is one of the largest daily newspapers in the U.S. Their interest in HCV is indicative of a growing awareness of the extent of the disease in this country. The article clearly focuses on the hope...
Alcoholism Facts
Title: Alcoholism Facts
Category: Health Facts
Created: 8/9/2005
Last Editorial Review: 8/29/2005
How Much Do New Doctors Know About Hepatitis C
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: How Much Do New Doctors Know About Hepatitis C
Added by glog on Dec 14, 2005 7:39 am (GMT -4)

A recent study evaluated the hepatitis C knowledge of primary care ... Only 41% of residents would vaccinate patients with hepatitis C against ... 66% recommended vaccination against hepatitis C -- though no hepatitis C vaccine exists ...... Read more...

Save, Share and Discover Info from Anywhere with BlinkBits Bookmarklets

Hepatitis C - Viral Hepatitis C

Viral Hepatitis C
... VIRAL HEPATITIS C. Historical Data ... In summary, viral hepatitis C has a long natural history with mostly benign course, therefore, the frequency of death ...

Hepatitis C - What is Hepatitis C?(NC)-Hepatitis C is an infectious virus that

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE. 1999. Viral persistence antibody to

THE CONTRIBUTIONS OF NONHUMAN PRIMATE RESEARCH TO HUMAN HEALTH
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195.

USDA Funded Projects
disease distribution will be applied to newly emeerged diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis.

P
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Sien-Sing Yang, Chao-Tien Hsu,

Viral hepatitis
ivral hepatitis / vrial hepatitis / viarl hepatitis / virla hepatitis / vira lhepatitis / Viral ehpatitis / Viral hpeatitis / Viral heaptitis / Viral

Hepatitis C - Hepatitis C Top Articles

Hepatitis C Top Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for chronic hepatitis B.

If you have hepatitis C, what vaccinations do you need?
The PDF version is identical to the original printed document and is suitable for making copies. Adobe Acrobat Reader is needed to view it.

MedlinePlus: Hepatitis C Infection Tied to Diabetes Risk
Hepatitis C Infection Tied to Diabetes Risk. Hepatitis C Infection Tied to Diabetes Risk. Printer-friendly version · E-mail this page to a friend

MedlinePlus Medical Encyclopedia: Hepatitis C
Hepatitis C infection is caused by hepatitis C virus (HCV). The prevalence of hepatitis C infection is approximately 4 million people in the United

eMedicine - Hepatitis C : Article by Sandeep Mukherjee, MD
Several small studies have reported a lower response rate to IFN alfa among black patients with chronic hepatitis C infection than among white patients.

Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Hepatitis C - Liver cancer, hep C clue

Liver cancer, hep C clue
Health24 - Scientists have long noted a link between chronic hepatitis C infection and an increased risk for liver cancer is that one of the hepatitis C virus proteins (NS5B) targets a

Watchdog says sick cons put public at risk
Boston Herald - Prisoner illness is also a top concern cited by a Romney administration commission in a new report on the need for reform in the state Department of Correction. diseases among them tuberculosis, skin lesions, hepatitis C and HIV because of woeful medical care prisoners who are going into prison with hepatitis C, HIV, tuberculosis, MRSA

XTL names CEO
TMCnet.com - clinical trials is XTL-6862, developed to prevent hepatitis C, known as HCV, re-infection following a liver transplant

Idenix to finalize pivotal trial of hepatitis C drug
Datamonitor - Idenix to finalize pivotal trial of hepatitis C drugAfter a meeting with the FDA, Idenix III clinical trial of its hepatitis C candidate, valopicitabine, in treatment-refractory

Vertex hepatitis C drug is fast-tracked
Washington Times - The Food and Drug Administration has fast tracked Vertex Pharmaceuticals' oral hepatitis C (HVC) drug review because it treats chronic hepatitis C, a serious and life-threatening

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C - Hepatitis B

Hepatitis B
Title: Hepatitis B
Category: Diseases and Conditions
Created: 1/26/2001 11:58:00 AM
Last Editorial Review: 9/21/2005
Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...
Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets Clearer
Category: Health News
Created: 12/8/2005 1:59:00 AM
Last Editorial Review: 12/8/2005 1:58:50 AM

Hepatitis C - National Hepatitis C Coalition Inc. - Offering Hope For Hepatitis C

National Hepatitis C Coalition Inc. - Offering Hope For Hepatitis C
Hep C Ribbon - Representing the ongoing fight for hepatitis C awareness Hep C Ribbon - Representing Hep C Advocacy Link · Hot Site award for this site

HCV Advocate.org
About Hcsp · Learn how you can support HCSP and expand our mission to educate and support the HCV. Special Features This Week's Postings Include:

Hep C Palace
Hepatitis C information, chat and support for people with HCV, their friends and family.

Hepatitis C Caring Ambassadors Program - Challenging Hepatitis C
HCCAP Newsletters | HCCAP Press Releases | HCV in the News | Read or Download Choices | Order Hep C Choices Book | Order Hep C Choices Flyer.

Click here to go to .
Click here to go to .

Hepatitis C - Hepatitis C Outreach Project Information Center

Hepatitis C Outreach Project Information Center
Chronic viral hepatitis C: management update. Klaus S. Gutfreund, Vincent G. Bain CMAJ 2000;162(6):827-33 ... Abstract Introduction Diagnosis of chronic viral hepatitis C Assessment of patients with chronic viral hepatitis C ... The management of chronic viral hepatitis C is evolving rapidly ...

FAQ - About Viral Hepatitis C - healthfinder
Answers to commonly asked questions about hepatitis C. Some topics covered include testing and diagnosis; method of infection; management and treatment of hepatitis C; and risk factors for health care workers.

The medical treatment of acute hepatitis C viral infection by interferon alpha
... and jaundice in this phase of acute viral hepatitis C (acute VHC). Clinical symptoms are not difference ... fact that patients after passed viral hepatitis C (only anti-HCV positive ...

Hepatitis C - Hepatitis C

Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....
Primary Biliary Cirrhosis
Title: Primary Biliary Cirrhosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005

Hepatitis C - Christmas in Onslow is all about helping out local families

Christmas in Onslow is all about helping out local families
Jacksonville Daily News - Miller has hepatitis-C and is sick a lot, so it's hard for him to work

The Deadly Shot
New York Times - The Deadly Shot Published: November 26, 2005 Millions of people in poor countries get sick and die from a common tool for getting well: the hypodermic syringe. one million people each year get hepatitis B this way, two million get hepatitis C and 650,000 get infected with H.I.V

Hepatitis C - HCV

HCV
Treatment Side Effects and Management New Special Patient Populations HCV SLIDE ARCHIVES HCV 1 st Edition Slides Epidemiology and Natural History Molecular Tools for the Diagnosis and Monitoring of

HCV
Originally one source of non-A non-B hepatitis (~90%?), hepatitis C virus (HCV) was first definitively identified by molecular cloning of the virus genome in 1989 ( Choo et al, Science 244: 359-62

Hepatitis C - Three Rivers Pharmaceuticals Announces FDA Final Approval of Ribasphere(R) (ribavirin, USP) Tablets 600mg, 400

Three Rivers Pharmaceuticals Announces FDA Final Approval of Ribasphere(R) (ribavirin, USP) Tablets 600mg, 400
Drug News Wire - alfa-2a for the treatment of Hepatitis C ('HCV'). Three Rivers Pharmaceuticals and PAR Pharmaceuticals will be shipping advance in the treatment of HCV since the launch of Pegasys(R

2.2% Liver Cancer developed Among SVRs; Sexual Dysfunction among HCV+
National AIDS Treatment Advocacy Project - Liver Cancer developed Among Sexual among HCV+ Conference Reports for NATAP AASLD American Association Cancer developed Among Sexual among HCV+ Reported by Jules Levin from AASLD

PR Newswire: Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monothera
Belga Direct Press Releases - HCV genotype 1 is the most commonform of the virus worldwide and is considered the most difficult to treatsuccessfully. patients chronically infected withhepatitis C virus (HCV) genotype 1 who were nonresponders to

Pegasys shows encouraging interim results for HCV patients in whom PegIntron therapy failed
InPharm.com - The study looked at early markers of the efficacy and safety of different regimens of Pegasys+Copegus combination therapy in 950 patients with HCV in whom previous treatment with PegIntron+Rebetol failed to generate a sustained virologic response. viral levels in hepatitis C (HCV) patients for whom treatment with PegIntron

FDA gives Fast Track status to Vertex's Hepatitis C treatment
Mass High Tech - to VX-950, an investigational oral hepatitis C virus (HCV) treatment being developed by Vertex Pharmaceuticals Inc and dramatic reduction in HCV RNA in HCV patients when VX-950

MULTICENTER RANDOMIZED TRIAL OF HCV TREATMENT WITH PEGINTERFERON-ALFA 2A (Pegasys) AND RIBAVIRIN AFTER LIVER T
National AIDS Treatment Advocacy Project - Methods: 97 patients were included, with recurrent HCV and a minimum of stage 1 fibrosis (METAVIR scoring) on a liver biopsy obtained 1 to 5 years after LT. 75% of patients received tacrolimus and 25% cyclosporine. - ()

Hepatitis C - Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease

Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
PR Newswire - Professor of Internal Medicine atUTMB, have been studying how Hepatitis C infection can damage or destroy theliver

Call for free condoms to combat spread of HIV in prisons
Guardian Unlimited - Prison healthcare, the report authors say, is 'substandard' and many prisoners have no access to condoms, disinfecting tablets, clean needles or healthcare information. tests to establish more accurate levels of HIV and hepatitis C infection.In order to avoid the spread of sexually

Ciphergen Biosystems, Inc. (CIPH) And University of Texas Medical Branch At Galveston Sign Collaboration Agree
BioSpace - Professor of Internal Medicine at UTMB, have been studying how Hepatitis C infection can damage or destroy the liver

Liver cancer, hep C clue
Health24 - Scientists have long noted a link between chronic hepatitis C infection and an increased risk for liver cancer has long been known that hepatitis C infection can lead to liver

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients
Aidsmap - Markers of liver damage due to hepatitis C infection that can be measured from blood samples are as effective in

Body Weight Correlates with Hepatocellular Cancer: Presented at AASLD
Doctors Guide - Previous studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC), he said in his presentation on November 13th. Dr. Body weight appears to influence the course of hepatitis C infection, with lower body weight being protective against